An interventional study of Preparation for Decision Making (PrepDM) Scale and Questionnaire in Labour Analgesia, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Recruiting at 1 site in Canada. Open to female participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital — 3 open to participants now, 3 under way, none of them phase 3. Labor Pain · Samuel Lunenfeld Research Institute, Mount Sinai Hospital.
Among the 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, this one has the largest planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2026, is one of 15 with no phase, and was the 22nd registered.
426 studies on the registry are indexed under Labor Pain; 76 are open to participants now.
Browse Labor Pain studies →3 of the 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital are open now, in 1 country. Recruiting first, the newest first:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Sites in Canada
Ages 18–50 · Women only · Healthy volunteers
Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Sites in Canada
Ages 18–50 · Women only · Healthy volunteers
By country, each count listing its studies:
Of the 31 Labor Pain studies recruiting now, 8 (26%) set no upper age limit and 23 (74%) stop at 75 or younger; 3 take children under 18; 20 take healthy volunteers.
This study: 18 Years to 55 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 100 across 349 interventional studies indexed under Labor Pain.
Median enrollment 40 across the 15 interventional studies, 30 across the 7 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 138 studies on the registry; 17 are open to participants now.
2 of the studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06572241Samuel Lunenfeld Research Institute, Mount Sinai HospitalQuality of Labour Epidural Analgesia With Intrathecal Morphine as a Component of Combined Spinal Epidural | 2026-12 |
| NCT07516171Samuel Lunenfeld Research Institute, Mount Sinai HospitalA Digital Educational Resource to Improve Preparedness for Shared Decision Making About Labour Analgesia | 2027-06 |
Add all 2 to your calendar (.ics) → With an account.
Among the 22 studies in Labor Pain by Samuel Lunenfeld Research Institute, Mount Sinai Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Labour analgesia decisions are often made under time pressure, while in pain, which may lead patients to feel unprepared or uninformed. Shared decision-making (SDM) enhances patient satisfaction, promotes alignment with personal values, and improves trust in clinical care. Digital tools can support SDM by providing accessible, evidence-based information.
The Society for Obstetric Anesthesia and Perinatology (SOAP) is an international organization made up of doctors who specialize in managing pain and anesthesia during pregnancy. Their focus is the wellbeing and safety of mothers and their babies from early pregnancy through delivery and recovery. The Painless Push digital resource educates mothers about ways to manage pain during labour.
This trial aims to evaluate whether directing patients to access to the website https://thepainlesspush.com/ improves preparedness for shared decision-making compared to the current care, which is access to the Mount Sinai Obstetric Anesthesia website.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Comparator: The Painless Push digital resource educates mothers about ways to manage pain during labour.
Other: Preparation for Decision Making (PrepDM) Scale · Other: Questionnaire
Control group: website currently available to patients.
Other: Preparation for Decision Making (PrepDM) Scale · Other: Questionnaire
Electronic questionnaire: (PrepDM) Scale, a 10-item validated tool scored from 0 to 100.
Electronic questionnaire, to determine clarity and understanding. Scored on 5-point Likert scale.
Preparation for Decision Making (PrepDM) score
PrepDM is a 10-item validated tool scored from 0 to 100. Higher scores reflect greater readiness for informed and shared decision-making
Time frame: Immediately following intervention (reading material)
Questionnaire - additional questions about digital material provided
Additional questions about the clarity of the information, perceived understanding, likelihood of recommending, and intent to engage in shared decision-making in future health decisions.
Time frame: Immediately following intervention (reading material)
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2026 (actual). Primary completion is estimated for Jun 2027, 11 months after the start.
Of 192 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's planned 11 months is above that.
Counting every sponsor, half of 194 studies reached it within 9 months; a quarter within 5 and three quarters within 14.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 8, 2026: start Apr 2026 → Jul 2026, primary completion Dec 2026 → Jun 2027 and completion Dec 2026 → Jun 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital →